Skip to main content

Cytomegalovirus Disease

3
Pipeline Programs
5
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
3
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
6100%

Competitive Landscape

5 companies ranked by most advanced pipeline stage

MSD
MSDIreland - Ballydine
1 program
1
LetermovirPhase 4Small Molecule1 trial
Active Trials
NCT04904614Completed32Est. Jan 2025
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
1 program
1
LetermovirPhase 4Small Molecule
CSL Seqirus
CSL SeqirusUK - Maidenhead
1 program
1
ValganciclovirPhase 4Small Molecule
Jazz Pharmaceuticals
Jazz PharmaceuticalsCA - Palo Alto
2 programs
BrincidofovirPHASE_3Small Molecule1 trial
BrincidofovirPHASE_3Small Molecule1 trial
Active Trials
NCT02439970Terminated5Est. Jan 2016
NCT02439957Terminated6Est. Jul 2016
CSL Behring
CSL BehringIL - Bradley
1 program
ValganciclovirPHASE_4Small Molecule1 trial
Active Trials
NCT01509404Completed40Est. Dec 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MSDLetermovir
CSL BehringValganciclovir
Jazz PharmaceuticalsBrincidofovir
Jazz PharmaceuticalsBrincidofovir

Clinical Trials (4)

Total enrollment: 83 patients across 4 trials

NCT04904614MSDLetermovir

Letermovir Use in Heart Transplant Recipients

Start: Jan 2022Est. completion: Jan 202532 patients
Phase 4Completed
NCT01509404CSL BehringValganciclovir

Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection

Start: Nov 2011Est. completion: Dec 201540 patients
Phase 4Completed
NCT02439970Jazz PharmaceuticalsBrincidofovir

A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease

Start: Sep 2015Est. completion: Jan 20165 patients
Phase 3Terminated
NCT02439957Jazz PharmaceuticalsBrincidofovir

A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus

Start: Sep 2015Est. completion: Jul 20166 patients
Phase 3Terminated

Related Jobs

Research Associate, Infectious Disease Virology

ModernaModerna
Cambridge, Massachusetts; Research
2w ago
$63K - $101K/yr

Manager, Statistical Programming

ModernaModerna
Bethesda, Maryland; Clinical Development
3w ago
$109K - $175K/yr

Senior Research Associate, Virology

ModernaModerna
Cambridge, Massachusetts; Research
1mo ago
$74K - $118K/yr

2026 Co-Op, Infectious Disease Research

ModernaModerna
Cambridge, Massachusetts
1mo ago
$42K - $125K/yr

Sr. Regional Sales Manager, Vaccines, Region Nord (m/w/d)

ModernaModerna
Remote
1mo ago

Sr. Regional Sales Manager, Vaccines, Region West (m/w/d)

ModernaModerna
Remote
2mo ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.